You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Which of the following is an anti - VEGF drug? and explain in detail?
Ans. is 'b' i.e., Bevacizumab Monoclonal AntibodyTargetIndicationTrastuzumabher-2/neuBreast cancerTositumomabCD 20B-cell NHLRituximabCD 20B-cell NHLlbritumomabCD 20B-cell NHLDaclizumabIL-2R (CD-25)ImmunosuppressantBasiliximabIL-2R (CD-25)I mmunosuppressantAbciximabGpII/IIIaAntiplateletPalivizumabFusion proteinRSVInfliximabTNF aRA,Crohn's diseaseEtanerceptTNF aRA (rheumatoid arthritis)OfatumumabCD 20SLEBelimumabBLySSLEEpratuzumabCD 22SLEOcrelizumabCD 20SLEAdalimumabTNF aRAAlefaceptLFA-3Plaque psoriasisAlemtuzumabCD 52B cell CLLBevacizumabVEGFColorectal carcinomaCetuximabEGFRColorectal carcinomaGemtuzumabCD 33AMLEfalizumabCD 1 la chain of LFAPsoriasisOmalizumabIgEBronchial asthmaNatalizumabIntegrin-a4Multiple sclerosisDonesumabRANK ligandOsteoporosisTocilizumabIL-6RSLEPanitumumabEGFRColorectal carcinomaRanibizomabVEGFNeovascular macular degenerationNimotuzumabEGFRSquamous cell carcinoma, gliomaEculizumabC5 complement componentParoxysomal nocturnal hemoglobinuria